Kemyth Biotech co., Ltd.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
1. Antibiotic Testing and Screening Platform
2. Kemyth Biotech co., Ltd. *Klebsiella pneumoniae* K1/K2 Serotyping Antigen Detection Kit
3. Pharmacokinetics and Biodistribution Testing Services
4. Beauty and Healthcare Products
(The content above was translated by AI.)
2. Kemyth Biotech co., Ltd. *Klebsiella pneumoniae* K1/K2 Serotyping Antigen Detection Kit
3. Pharmacokinetics and Biodistribution Testing Services
4. Beauty and Healthcare Products
(The content above was translated by AI.)
Founded Year
2015
Unified Business No.
42620185
Status
Active
Number of Employees
0
Total Paid-in
Capital
20,000,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
KeMyth Biotech was established in July 2015 and is committed to transforming research achievements into industrial innovation. With the development of the company, our areas of focus have expanded from infectious diseases to broader health challenges. Our core projects include antibiotic testing and screening platforms, rapid diagnostic reagents, novel drug development, as well as beauty and health products, all of which are developed by a professional team and promoted in cooperation with industry partners. By combining cutting-edge research with practical applications, we are dedicated to enhancing medical quality and improving human health and quality of life. In the future, we will continue to invest in the research, development, and application of innovative technologies, strengthen domestic and international cooperation, and expand our global market layout, aiming to become a key driver leading the development of the biotechnology industry and creating more value for human health.
(The content above was translated by AI.)
(The content above was translated by AI.)
